Jeil Pharmaceutical, Stem Cell Theme Rises 29.95% Up

On the 4th, the stem cell theme rose by 3.03% compared to the previous day, showing strength, while Jeil Yakpum, a related stock attracting attention, surged by 29.95% compared to the previous day. Jeil Yakpum is known as a company spun off from Jeil Pharma Holdings.

[Graph] Stem Cell Theme Major Stocks Price Change



According to the analysis by Thinkpool Robo Algorithm RASSI, Jeil Yakpum’s quant financial score is 13.63 points, with higher stability and profitability scores than the average of other stem cell-related stocks, but its quant financial ranking was only 13th out of 23 stocks. On the other hand, Donggu Bio Pharm ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.

[Table] Top Financial Scores within the Theme


※ The quant financial score is the result of the robo algorithm’s analysis based on each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.